Table A1 CHEERS 2022 checklist Topic No....

Table A1

CHEERS 2022 checklist

Topic	No.	Item	Location where the item is reported
Title	1	Identify the study as an economic evaluation and specify the interventions being compared	Title page
Abstract	2	Provide a structured summary that highlights context, key methods, results, and alternative analyses	Page 1
Introduction
Background and objectives	3	Give the context for the study, the study question, and its practical relevance for decision-making in policy or practice	Introduction, pages 1-2
Methods
Health economic analysis plan	4	Indicate whether a health economic analysis plan was developed and where available	CHEERS, Appendix
Study population	5	Describe characteristics of the study population (such as age range, demographics, socioeconomic or clinical characteristics)	Methods page 3, Results page 5
Setting and location	6	Provide relevant contextual information that may influence findings	Methods page 3
Comparators	7	Describe the interventions or strategies being compared and why chosen	Methods page 3, Table 1
Perspective	8	State the perspective(s) adopted by the study and why chosen	Introduction page 2, Methods page 3
Time horizon	9	State the time horizon for the study and why appropriate	Methods page 3
Discount rate	10	Report the discount rate(s) and reason chosen	Methods page 5
Selection of outcomes	11	Describe what outcomes were used as the measure(s) of benefit(s) and harm(s)	Methods pages 4-5
Measurement of outcomes	12	Describe how outcomes used to capture benefit(s) and harm(s) were measured	Methods pages 4-5
Valuation of outcomes	13	Describe the population and methods used to measure and value outcomes	Methods pages 3-5
Measurement and valuation of resources and costs	14	Describe how costs were valued	Methods pages 4-5
Currency, price date, and conversion	15	Report the dates of the estimated resource quantities and unit costs, plus the currency and year of conversion	Methods pages 4-5
Rationale and description of model	16	If modelling is used, describe in detail and why used. Report if the model is publicly available and where it can be accessed	Not applicable
Analytics and assumptions	17	Describe any methods for analyzing or statistically transforming data, any extrapolation methods, and approaches for validating any model used	Methods page 5
Characterizing heterogeneity	18	Describe any methods used for estimating how the results of the study vary for subgroups	Not applicable
Characterizing distributional effects	19	Describe how impacts are distributed across different individuals or adjustments made to reflect priority populations	Introduction page 1, Methods page 3, Table 1
Characterizing uncertainty	20	Describe methods to characterize any sources of uncertainty in the analysis	Methods page 4, discussion page 10
Approach to engagement with patients and others affected by the study	21	Describe any approaches to engage patients or service recipients, the general public, communities, or stakeholders (such as clinicians or payers) in the design of the study	Methods pages 3-5
Results
Study parameters	22	Report all analytic inputs (such as values, ranges, references), including uncertainty or distributional assumptions	Results pages 5-8
Summary of main results	23	Report the mean values for the main categories of costs and outcomes of interest and summarize them in the most appropriate overall measure	Results pages 5-8, Figures 1–3
Effect of uncertainty	24	Describe how uncertainty about analytic judgements, inputs, or projections affect findings. Report the effect of the choice of discount rate and time horizon, if applicable	Results pages 5-8, discussion pages 8-10
Effect of engagement with patients and others affected by the study	25	Report on any difference in patient/service recipient, general public, community, or stakeholder involvement made to the approach or findings of the study	Not applicable
Discussion
Study findings, limitations, generalizability, and current knowledge	26	Report key findings, limitations, ethical or equity considerations not captured, and how these could affect patients, policy, or practice	Discussion pages 8-10
Other relevant information
Source of funding	27	Describe how the study was funded and any role of the funder in the identification, design, conduct, and reporting of the analysis	Title page 1
Conflicts of interest	28	Report authors' conflicts of interest according to journal or International Committee of Medical Journal Editors requirements	Conflicts of interest have been reported according to the guidance of the International Journal of Workplace Health Management

Topic	No.	Item	Location where the item is reported
Title	1	Identify the study as an economic evaluation and specify the interventions being compared	Title page
Abstract	2	Provide a structured summary that highlights context, key methods, results, and alternative analyses	Page 1
Introduction
Background and objectives	3	Give the context for the study, the study question, and its practical relevance for decision-making in policy or practice	Introduction, pages 1-2
Methods
Health economic analysis plan	4	Indicate whether a health economic analysis plan was developed and where available	CHEERS, Appendix
Study population	5	Describe characteristics of the study population (such as age range, demographics, socioeconomic or clinical characteristics)	Methods page 3, Results page 5
Setting and location	6	Provide relevant contextual information that may influence findings	Methods page 3
Comparators	7	Describe the interventions or strategies being compared and why chosen	Methods page 3, Table 1
Perspective	8	State the perspective(s) adopted by the study and why chosen	Introduction page 2, Methods page 3
Time horizon	9	State the time horizon for the study and why appropriate	Methods page 3
Discount rate	10	Report the discount rate(s) and reason chosen	Methods page 5
Selection of outcomes	11	Describe what outcomes were used as the measure(s) of benefit(s) and harm(s)	Methods pages 4-5
Measurement of outcomes	12	Describe how outcomes used to capture benefit(s) and harm(s) were measured	Methods pages 4-5
Valuation of outcomes	13	Describe the population and methods used to measure and value outcomes	Methods pages 3-5
Measurement and valuation of resources and costs	14	Describe how costs were valued	Methods pages 4-5
Currency, price date, and conversion	15	Report the dates of the estimated resource quantities and unit costs, plus the currency and year of conversion	Methods pages 4-5
Rationale and description of model	16	If modelling is used, describe in detail and why used. Report if the model is publicly available and where it can be accessed	Not applicable
Analytics and assumptions	17	Describe any methods for analyzing or statistically transforming data, any extrapolation methods, and approaches for validating any model used	Methods page 5
Characterizing heterogeneity	18	Describe any methods used for estimating how the results of the study vary for subgroups	Not applicable
Characterizing distributional effects	19	Describe how impacts are distributed across different individuals or adjustments made to reflect priority populations	Introduction page 1, Methods page 3, Table 1
Characterizing uncertainty	20	Describe methods to characterize any sources of uncertainty in the analysis	Methods page 4, discussion page 10
Approach to engagement with patients and others affected by the study	21	Describe any approaches to engage patients or service recipients, the general public, communities, or stakeholders (such as clinicians or payers) in the design of the study	Methods pages 3-5
Results
Study parameters	22	Report all analytic inputs (such as values, ranges, references), including uncertainty or distributional assumptions	Results pages 5-8
Summary of main results	23	Report the mean values for the main categories of costs and outcomes of interest and summarize them in the most appropriate overall measure	Results pages 5-8, Figures 1–3
Effect of uncertainty	24	Describe how uncertainty about analytic judgements, inputs, or projections affect findings. Report the effect of the choice of discount rate and time horizon, if applicable	Results pages 5-8, discussion pages 8-10
Effect of engagement with patients and others affected by the study	25	Report on any difference in patient/service recipient, general public, community, or stakeholder involvement made to the approach or findings of the study	Not applicable
Discussion
Study findings, limitations, generalizability, and current knowledge	26	Report key findings, limitations, ethical or equity considerations not captured, and how these could affect patients, policy, or practice	Discussion pages 8-10
Other relevant information
Source of funding	27	Describe how the study was funded and any role of the funder in the identification, design, conduct, and reporting of the analysis	Title page 1
Conflicts of interest	28	Report authors' conflicts of interest according to journal or International Committee of Medical Journal Editors requirements	Conflicts of interest have been reported according to the guidance of the International Journal of Workplace Health Management

Source(s): Husereau et al. (2022), CHEERS (2022) Explanation and Elaboration: A Report of The Professional Society for Health Economics and Outcomes Research (ISPOR) CHEERS II Good Practices Task Force. Value Health 2022; 25. Link to the DOI

[ViewLarge]

Sharing Unavailable